Novo Holdings Neuronetics, Inc. Transaction History

Novo Holdings

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $935,825 - $3.02 Million	-514,190 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.61 $548,041 - $1.01 Million	-388,682 Reduced 43.05%	514,190 $992,000
Q1 2020 May 15, 2020	BUY	$1.28 - $4.5 $212,856 - $748,323	166,294 Added 22.58%	902,872 $1.71 Million
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $436,166 - $997,880	108,230 Added 17.22%	736,578 $3.31 Million
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $378,520 - $593,516	45,550 Added 7.82%	628,348 $5.22 Million
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $520,182 - $994,125	57,798 Added 11.01%	582,798 $7.29 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $12.8 Million - $19.7 Million	525,000 New	525,000 $0

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $23.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.